Clinical Trial Update: One-Year Effect on Levodopa Equivalent Daily Dose of Thalamic VIM Nucleus Stimulation Compared to Subthalamic Nucleus Stimulation in Patients With Parkinson's Disease

View source ↗

Summary

This clinical trial compares one-year changes in Levodopa equivalent daily dose when using thalamic VIM stimulation versus subthalamic stimulation in Parkinson …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Parkinson Disease (PD), Deep Brain Stimulation | Status: NOT_YET_RECRUITING